| |
I'm doing a phd in chemistry ibuprofen 400 mg dosage For those who don't recall the specifics, Facebook originally filed to sell 337 million shares at between $28 and $35 per share (a particularly wide range). It later increased the range to $34-$38 per share, and ultimately priced 421 million shares at the high end, raising approximately $16 billion. All well and good until it was time for the shares to actually begin trading. The first glitch was immediately apparent: NASDAQ couldn't handle the volume, delaying orders for more than an hour. Part of this was due to massive buy-side demand. Some of it was because of an unexpected rash of sell orders, prompted by a downward revision in revenue projections (which Facebook had soft-sold in its S-1 document, but made more explicit to certain bank analysts).
|
|
- 20/1/14(火) 6:26 -
